Quince Therapeutics, Inc. (QNCX) OrphAI Therapeutics Inc - M&A Call - Slideshow
Quince Therapeutics, Inc. has published a slide deck related to its recent M&A call with OrphAI Therapeutics Inc. The slide deck includes details from their earnings summary, highlighting an EPS of $2.88 that exceeded expectations. The company reported no revenue for the quarter.
- ▪Quince Therapeutics, Inc. reported an EPS of $2.88, beating estimates by $5.48.
- ▪The company's revenue for the quarter was reported as $0.00.
- ▪The slide deck was published in conjunction with an M&A call involving OrphAI Therapeutics Inc.
Seeking Alpha files mainly under finance. We currently carry 6,432 of its stories.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4906210-quince-therapeutics-inc-qncx-orphai-therapeutics-inc-m-and-a-call-slideshow"},"author":{"@type":"Person","name":"SA Transcripts","url":"https://seekingalpha.com/author/sa-transcripts"},"publisher":{"@context":"http://schema.org","@type":"Organization","address":{"@type":"PostalAddress","streetAddress":"244 5th Ave","addressLocality":"New York","addressRegion":"NY","postalCode":"10001","addressCountry":"US"},"alternateName":["SeekingAlpha","SA"],"brand":[{"@type":"Brand","name":"Seeking Alpha Premium","url":"https://seekingalpha.com/subscriptions/premium"},{"@type":"Brand","name":"Seeking Alpha…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
